Anzeige
Mehr »
Donnerstag, 24.07.2025 - Börsentäglich über 12.000 News
Neubewertung voraus? Wird die Aktivierung der EU-Lizenz zum Kurs-Katalysator für die Neubewertung?
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

Aktuelle News von pharmaphorum

  • 24 h
  • letzte 200 News
ZeitAktuelle Nachrichten
05.06.Neuralink raises $650m to widen use of brain implants
04.06.Ascletis says oral acne drug shows "exceptional efficacy"
04.06.Hims & Hers buys Zava to form European beachhead
04.06.MSD rumoured to be eyeing $3bn+ MoonLake takeover
04.06.ASCO 25: Sanofi hopes on-body delivery will boost Sarclisa
04.06.ASCO 25: J&J combo pill may see wider use in prostate cancer
03.06.Amid staff cuts, FDA looks to AI to 'optimise' reviews
03.06.ASCO 25: Enhertu bids for earlier use in HER2+ breast cancer
02.06.Consolidation in psychedelics as atai pairs with Beckley
02.06.BioNTech flips its cancer bispecific to BMS for a big profit
02.06.ASCO 25: AZ pitches upfront oral SERD use in breast cancer
02.06.23andMe founder isn't giving up her bid to regain control
02.06.Sanofi draws up $9.1bn plan to buy Blueprint Medicines
30.05.Summit shrugs off survival miss with its VEGF bispecific
30.05.Astellas adds to claudin clout with $1.3bn+ Evopoint deal
30.05.Roche builds case for MS drug with two-year efficacy data
30.05.Axe falls on Stealth Bio staff after FDA rejects lead drug
30.05.GRIN raises $140m for epilepsy drug, and other financings
29.05.MSD and Daiichi Sankyo pull HER3-DXd's FDA filing
29.05.Old COVID tweet lands Pfizer in new trouble with PMCPA
29.05.Moderna's $760m-plus flu vaccine contracts are nixed by HHS
29.05.Data sets up filing of new GSK antibiotic this year
29.05.Eisai says patent win blocks Lenvima generic to 2036
28.05.InflaRx stock halves after it drops lead drug
28.05.FDA fast-tracks Teva's coeliac disease treatment